SANTA ANA, CA--(NewMediaWire - Feb 22, 2016) - ADVANTIS
CORPORATION (OTC
PINK: ADVT) delivered the first order of LipMedRX Anti-Flu
& Cold Lip Balm Protectant to its pilot 7-Eleven and 76 gas
station last week, and is now available for retail sale.
Advantis Corp. has an exclusive distribution agreement with
LipMedRX, and the delivery of their lip balm to the Southern
California 7-Eleven and 76 gas station is the first time it will be
available for retail purchase. The company plans on completing more
deliveries and securing agreements with additional stores in the
coming weeks. "Advantis has fulfilled its first purchase order with
7-Eleven and 76 Gas Stations," Advantis Corp. CEO, Jeremy Foti,
said. "There will be many more to come, and we are currently
negotiating with several national and international chain stores. I
am proud to bring this revolutionary Anti-Flu & Cold Lip Balm
Protectant to market, and we are excited to fill the overwhelming
demand for this product."
LipMedRX is an innovative anti-germ lip balm protectant, which
studies have shown to be highly effective in killing those germs
associated with the flu and the common cold. According to a report
released by LipMedRX, LLC, the Anti-Flu & Cold Lip Balm
Protectant is the first ever lip balm that kills germs on the lips
before they can enter the body. The product was designed to provide
protection from germs while acting as a moisturizing agent that
keeps lips soft and smooth.
Foti said they wanted to launch the product in a controlled
distribution environment before spreading the product to retail
outlets throughout the US and internationally. "We will effectively
gauge consumer demand and we are targeting ideal retail chains for
further distribution," Foti explained. "We are implementing a
proven marketing strategy that will ensure escalating revenues. A
product like this is long overdue and will soon be available
internationally." Foti later added that Advantis Corp. will be
making the lip balm available for retail sale, as well as at the
wholesale level.
ABOUT Advantis Corporation
Advantis Corporation (ADVT)
focuses on the development of innovative products that supply the
medical, research, and pharmaceutical industries. The company
additionally establishes domestic and international partnerships
with businesses that develop and sell proprietary consumer products
and services. Product lines for consumer health care, music and
entertainment sectors are in development.
Forward Looking Statements: This news release contains
forward-looking statements made by ADVANTIS CORPORATION. All such
statements included in this press release, other than statements of
historical fact, are forward-looking statements. Although
management believes that the expectations reflected in such
forward-looking statements are reasonable, it can give no assurance
that such expectations will prove to have been correct. Actual
results may differ materially from those indicated by these
statements. The following risk factors, among others, could cause
actual results to differ materially from those described in any
forward- looking statements. These risks and uncertainties include,
but are not limited to, economic conditions, changes in the law or
regulations, demand for products of the Company, the effects of
competition and other factors that could cause actual results to
differ materially from those projected or represented in the
forward looking statements. Forward-looking statements are
typically identified by the words: believe, expect, anticipate,
intend, estimate, and similar expressions or which by their nature
refer to future events. The Company is not entitled to rely on the
safe harbor provisions of Section 27A of the Securities Act of 1933
and Section 21E of the Securities Exchange Act of 1934 because it
is not registered under either Act.